| PLCG2 |
PLCG2: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-2 |
EPHB1 |
EPHT2, EPHB1, NET: Ephrin type-B receptor 1 precursor |
0.477 |
Evidence |
|
| PLCG2 |
PLCG2: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-2 |
EPHB4 |
EPHB4, HTK, TYRO11: Ephrin type-B receptor 4 precursor |
0.477 |
Evidence |
|
| PLCG2 |
PLCG2: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-2 |
EPHA5 |
EPHA5, EHK1, HEK7: Ephrin type-A receptor 5 precursor |
0.477 |
Evidence |
|
| PLCG2 |
PLCG2: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-2 |
EPHB3 |
EPHB3, ETK2, HEK2, TYRO6: Ephrin type-B receptor 3 precursor |
0.477 |
Evidence |
|
| PLCG2 |
PLCG2: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-2 |
SYK |
SYK: Tyrosine-protein kinase SYK |
0.477 |
Evidence |
|
| PLCG2 |
PLCG2: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-2 |
ZAP70 |
ZAP70: Uncharacterized protein ZAP70 |
0.477 |
Evidence |
|
| PLCG2 |
PLCG2: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-2 |
FRK |
FRK, PTK5, RAK: Tyrosine-protein kinase FRK |
0.477 |
Evidence |
|
| PLCG2 |
PLCG2: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-2 |
TXK |
TXK, PTK4: Tyrosine-protein kinase TXK |
0.477 |
Evidence |
|
| PLCG2 |
PLCG2: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-2 |
TEC |
TEC, PSCTK4: Tyrosine-protein kinase Tec |
0.477 |
Evidence |
|
| PLCG2 |
PLCG2: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-2 |
CSK |
CSK: Tyrosine-protein kinase CSK |
0.477 |
Evidence |
|
| PLCG2 |
PLCG2: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-2 |
KDR |
KDR, FLK1: Vascular endothelial growth factor receptor 2 precursor |
0.477 |
Evidence |
O
|
| PLCG2 |
PLCG2: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-2 |
TYK2 |
TYK2: Non-receptor tyrosine-protein kinase TYK2 |
0.477 |
Evidence |
|
| PLCG2 |
PLCG2: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-2 |
EPHB2 |
EPHB2, DRT, EPHT3, EPTH3, ERK, HEK5, TYRO5: Ephrin type-B receptor 2 precursor |
0.477 |
Evidence |
|
| PLCG2 |
PLCG2: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-2 |
EPHA8 |
EPHA8, EEK, KIAA1459: Ephrin type-A receptor 8 precursor |
0.477 |
Evidence |
|
| PLCG2 |
PLCG2: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-2 |
EPHA2 |
EPHA2, ECK: Ephrin type-A receptor 2 precursor |
0.477 |
Evidence |
|
| PLCG2 |
PLCG2: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-2 |
FGFR4 |
FGFR4, JTK2, TKF: Fibroblast growth factor receptor 4 precursor |
0.477 |
Evidence |
|
| PLCG2 |
PLCG2: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-2 |
ERBB3 |
ERBB3, HER3: Receptor tyrosine-protein kinase erbB-3 precursor |
0.477 |
Evidence |
|
| PLCG2 |
PLCG2: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-2 |
EPHA1 |
EPHA1, EPH, EPHT, EPHT1: Ephrin type-A receptor 1 precursor |
0.477 |
Evidence |
|
| PLCG2 |
PLCG2: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-2 |
FLT1 |
FLT1, FLT, FRT: Vascular endothelial growth factor receptor 1 precursor |
0.477 |
Evidence |
|
| FER |
FER, TYK3: Proto-oncogene tyrosine-protein kinase FER |
TNK2 |
TNK2, ACK1: Activated CDC42 kinase 1 |
0.477 |
Evidence |
|
| FER |
FER, TYK3: Proto-oncogene tyrosine-protein kinase FER |
FLT4 |
VEGFR3 long form |
0.477 |
Evidence |
|
| FER |
FER, TYK3: Proto-oncogene tyrosine-protein kinase FER |
VAV2 |
VAV2: Uncharacterized protein VAV2 |
0.477 |
Evidence |
|
| FER |
FER, TYK3: Proto-oncogene tyrosine-protein kinase FER |
PLCG2 |
PLCG2: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-2 |
0.477 |
Evidence |
|
| NCK1 |
NCK1, NCK: Cytoplasmic protein NCK1 |
TNK2 |
TNK2, ACK1: Activated CDC42 kinase 1 |
0.477 |
Evidence |
|
| NCK1 |
NCK1, NCK: Cytoplasmic protein NCK1 |
FLT4 |
VEGFR3 long form |
0.477 |
Evidence |
|